A rare autoimmune disease, lupus can affect multiple organs and cause varying symptoms, complicating care for both patients and caregivers.
For ready reference, this article consolidates some of the frequently asked questions (FAQs) about lupus.
What is lupus?
Lupus is a chronic autoimmune disease that develops when a person’s immune system mistakenly attacks the body’s own organs and tissues, causing inflammation, damage, and pain.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.